{"id":"https://openalex.org/W4362551113","doi":"https://doi.org/10.1158/2326-6066.22537004","title":"Supplementary Table 1 from Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines","display_name":"Supplementary Table 1 from Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362551113","doi":"https://doi.org/10.1158/2326-6066.22537004"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.22537004","doi":"https://doi.org/10.1158/2326-6066.22537004","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22537004","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.22537004","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003220273","display_name":"Benedetto Farsaci","orcid":"https://orcid.org/0000-0001-8275-2561","observed_orcids":["https://orcid.org/0000-0001-8275-2561"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benedetto Farsaci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052157883","display_name":"Renee Nicole Donahue","orcid":"https://orcid.org/0000-0002-6828-3073","observed_orcids":["https://orcid.org/0000-0002-6828-3073"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renee N. Donahue","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004391035","display_name":"Michael A. Coplin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Coplin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025568372","display_name":"Italia Grenga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Italia Grenga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001132987","display_name":"Lauren Marissa Lepone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lauren M. Lepone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059504870","display_name":"Alfredo Molinolo","orcid":"https://orcid.org/0000-0001-8412-2889","observed_orcids":["https://orcid.org/0000-0001-8412-2889"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alfredo A. Molinolo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5003174995","display_name":"James W. Hodge","orcid":"https://orcid.org/0000-0001-5282-3154","observed_orcids":["https://orcid.org/0000-0001-5282-3154"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James W. Hodge","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.8080999851226807,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.8080999851226807,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.12430000305175781,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.044599998742341995,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.8659999966621399},{"id":"https://openalex.org/keywords/antiangiogenic-tyrosine-kinase-inhibitors","display_name":"antiangiogenic tyrosine kinase inhibitors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/therapeutic-vaccines","display_name":"therapeutic vaccines","score":0.7850000262260437},{"id":"https://openalex.org/keywords/tumor-infiltrating-macrophages","display_name":"tumor-infiltrating macrophages","score":0.9079999923706055},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.9490000009536743},{"id":"https://openalex.org/keywords/4t1-breast-cancer-model","display_name":"4T1 breast cancer","score":0.8320000171661377},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6079999804496765},{"id":"https://openalex.org/keywords/twist","display_name":"Twist","score":0.4659999907016754}],"concepts":[{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6807173490524292},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5836198329925537},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.55316561460495},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49208778142929077},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39603668451309204},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32928580045700073},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20184272527694702},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06423991918563843}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2326-6066.22537004","doi":"https://doi.org/10.1158/2326-6066.22537004","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22537004","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/2326-6066.22537004.v1","doi":"https://doi.org/10.1158/2326-6066.22537004.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22537004.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.22537004","doi":"https://doi.org/10.1158/2326-6066.22537004","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22537004","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362551234","https://openalex.org/W4392722654","https://openalex.org/W1972475269","https://openalex.org/W2324902637","https://openalex.org/W2149436029","https://openalex.org/W2808318094","https://openalex.org/W1976358776","https://openalex.org/W2037819715","https://openalex.org/W4297816424","https://openalex.org/W1999963706"],"abstract_inverted_index":{"Effect":[0],"of":[1,16],"sunitinib":[2,8],"alone,":[3,6],"rMVA-Twist-TRICOM":[4],"vaccine":[5,12],"or":[7],"in":[9,21],"combination":[10],"with":[11],"on":[13],"the":[14,22],"phenotype":[15],"tumor-infiltrating":[17],"MDSCs":[18],"and":[19],"TAMs":[20],"4T1":[23],"breast":[24],"tumor":[25],"model.":[26]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}
